We are live on ! Find out more
Allspring Global Investments

Allspring Global Investments Portfolio holdings

AUM $65.2B
1-Year Est. Return 39.42%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+39.42%
3 Year Est. Return
+106.84%
5 Year Est. Return
10 Year Est. Return
AUM
$61.3B
AUM Growth
-$2.74B
Cap. Flow
-$2.2B
Cap. Flow %
-3.59%
Top 10 Hldgs %
14.45%
Holding
2,566
New
269
Increased
893
Reduced
1,095
Closed
190

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Industrials 14.2%
3 Financials 11.99%
4 Consumer Discretionary 10.18%
5 Healthcare 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLB icon
1726
GitLab
GTLB
$7.32B
$185K ﹤0.01%
3,726
+3,152
+549% +$164K
AFCG
1727
AFC Gamma
AFCG
$68.7M
$184K ﹤0.01%
22,086
-1,293
-6% -$10.6K
ASX icon
1728
ASE Group
ASX
$103B
$183K ﹤0.01%
16,023
+1,046
+7% +$11.3K
DDS icon
1729
Dillards
DDS
$9.59B
$181K ﹤0.01%
410
+402
+5,025% +$174K
EMBC icon
1730
Embecta
EMBC
$290M
$180K ﹤0.01%
14,383
-10,210
-42% -$124K
CFB
1731
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$178K ﹤0.01%
12,697
-131
-1% -$1.69K
MPT
1732
Medical Properties Trust
MPT
$2.51B
$177K ﹤0.01%
41,159
+1,447
+4% +$6.93K
EFSC icon
1733
Enterprise Financial Services Corp
EFSC
$2.4B
$177K ﹤0.01%
4,335
-45
-1% -$1.75K
PMT
1734
PennyMac Mortgage Investment
PMT
$828M
$177K ﹤0.01%
+12,872
New +$180K
PGNY icon
1735
Progyny
PGNY
$1.99B
$177K ﹤0.01%
6,179
-81
-1% -$2.44K
BCS icon
1736
Barclays
BCS
$94.6B
$174K ﹤0.01%
16,287
+6,818
+72% +$70.9K
OSW icon
1737
OneSpaWorld
OSW
$2.73B
$174K ﹤0.01%
11,341
+11,256
+13,242% +$160K
OLO
1738
DELISTED
Olo Inc
OLO
$173K ﹤0.01%
39,231
-405
-1% -$1.92K
FRSH icon
1739
Freshworks
FRSH
$3.51B
$173K ﹤0.01%
13,614
-141
-1% -$2.11K
CWK icon
1740
Cushman & Wakefield Ltd
CWK
$3.37B
$172K ﹤0.01%
+16,576
New +$171K
TAC icon
1741
TransAlta
TAC
$3.99B
$172K ﹤0.01%
+24,300
New +$166K
E icon
1742
ENI
E
$79.1B
$171K ﹤0.01%
5,542
+3,218
+138% +$102K
BFH icon
1743
Bread Financial
BFH
$4.51B
$170K ﹤0.01%
3,821
-3,479
-48% -$136K
FOLD
1744
DELISTED
Amicus Therapeutics
FOLD
$170K ﹤0.01%
17,099
-81
-0.5% -$831
PRVA icon
1745
Privia Health
PRVA
$2.78B
$170K ﹤0.01%
9,758
+788
+9% +$14K
EPR icon
1746
EPR Properties
EPR
$4.73B
$169K ﹤0.01%
4,025
+15
+0.4% +$617
NUVL
1747
DELISTED
Nuvalent
NUVL
$168K ﹤0.01%
2,212
-23
-1% -$1.64K
FTRE icon
1748
Fortrea Holdings
FTRE
$1.69B
$167K ﹤0.01%
7,170
-803
-10% -$24.9K
MRC
1749
DELISTED
MRC Global
MRC
$167K ﹤0.01%
+12,936
New +$162K
ELAN icon
1750
Elanco Animal Health
ELAN
$11.2B
$165K ﹤0.01%
11,438
+1,637
+17% +$26.2K

Similar funds

Allspring Global Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Allspring Global Investments held 2,566 positions worth $61.3B, down 4.3% from $64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Allspring Global Investments withdrew a net $2.2B in Q2 2024, closing 190 positions and reducing 1,095 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $168M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

Against the trend, Allspring Global Investments opened a new position in Franco-Nevada worth $19.4M.

  • Allspring Global Investments's largest Q2 2024 buy was Franco-Nevada: 2,332,483 shares worth $19.4M.
  • Allspring Global Investments added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $116M increase.
  • Allspring Global Investments's biggest Q2 2024 reduction was Carlisle Companies, cutting an estimated $171M.
  • Allspring Global Investments fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $168M.
  • Allspring Global Investments's ten largest holdings make up 14% of its $61.3B portfolio in Q2 2024.
  • Allspring Global Investments opened 269 new positions and closed 190 in Q2 2024.
  • Allspring Global Investments's portfolio value fell 4.3% quarter-over-quarter to $61.3B.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.